Terms: = Lymphoma AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR
41 results:
1. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop.
Nejati R; Amador C; Czader M; Thacker E; Thakkar D; Dave SS; Dogan A; Duffield A; Goodlad JR; Ott G; Wasik MA; Xiao W; Cook JR
Am J Clin Pathol; 2023 Jun; 159(6):598-613. PubMed ID: 37085150
[TBL] [Abstract] [Full Text] [Related]
2. Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features.
Povýšil C; Hojný J; Kaňa M
Folia Biol (Praha); 2022; 68(3):112-124. PubMed ID: 36689318
[TBL] [Abstract] [Full Text] [Related]
3. Identification of prognostic factors in classic Hodgkin lymphoma by integrating whole slide imaging and next generation sequencing.
Santisteban-Espejo A; Bernal-Florindo I; Perez-Requena J; Atienza-Cuevas L; Catalina-Fernandez I; Fernandez-Valle MDC; Romero-Garcia R; Garcia-Rojo M
Mol Omics; 2022 Dec; 18(10):1015-1028. PubMed ID: 36382626
[TBL] [Abstract] [Full Text] [Related]
4. Blockade of FGF2/fgfr2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia.
Tian C; Li Y; Wang L; Si J; Zheng Y; Kang J; Wang Y; You MJ; Zheng G
Cell Death Dis; 2022 Nov; 13(11):922. PubMed ID: 36333298
[TBL] [Abstract] [Full Text] [Related]
5. Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine Leiomyoma.
Kuisma H; Jokinen V; Pasanen A; Heikinheimo O; Karhu A; Välimäki N; Aaltonen L; Bützow R
Am J Surg Pathol; 2022 Aug; 46(8):1126-1136. PubMed ID: 35426837
[TBL] [Abstract] [Full Text] [Related]
6. [Development of acute kidney injury prognostic model for critically ill patients based on MIMIC-III database].
Li M; Yang H; Yang W; Wei B; Zhang Y; Xie R; Chu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):949-954. PubMed ID: 34590562
[TBL] [Abstract] [Full Text] [Related]
7. NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
Sánchez-Herrero E; Serna-Blasco R; Ivanchuk V; García-Campelo R; Dómine Gómez M; Sánchez JM; Massutí B; Reguart N; Camps C; Sanz-Moreno S; Calabuig-Fariñas S; Jantus-Lewintre E; Arnal M; Fernández-Orth D; Calvo V; González-Rumayor V; Provencio M; Romero A
Mol Oncol; 2021 Sep; 15(9):2363-2376. PubMed ID: 34058070
[TBL] [Abstract] [Full Text] [Related]
8. Nuclear fgfr2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Cattaneo F; Ammendola R; Esposito G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924850
[TBL] [Abstract] [Full Text] [Related]
9. Novel Mutations in a Lethal Case of lymphomatous Adult T Cell lymphoma with Cryptic Myocardial Involvement.
Hashemi Zonouz T; Abdulbaki R; Bandyopadhyay BC; Nava VE
Curr Oncol; 2021 Feb; 28(1):818-824. PubMed ID: 33562071
[TBL] [Abstract] [Full Text] [Related]
10. Erdafitinib as a Novel and Advanced Treatment Strategy of Metastatic Urothelial Carcinoma.
Bansal P; Dwivedi DK; Hatwal D; Sharma P; Gupta V; Goyal S; Maithani M
Anticancer Agents Med Chem; 2021; 21(18):2478-2486. PubMed ID: 33475078
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of Bone Tissue Condition in Patients with Diffuse Large B-Cell lymphoma without Bone Marrow Involvement.
Fastova EA; Magomedova AU; Kravchenko SK; Petinati NA; Sats NV; Drize NI; Savchenko VG
Bull Exp Biol Med; 2020 Sep; 169(5):677-682. PubMed ID: 32986209
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA MEG3 Participates in Caerulein-Induced Inflammatory Injury in Human Pancreatic Cells via Regulating miR-195-5p/fgfr2 Axis and Inactivating NF-κB Pathway.
Chen X; Song D
Inflammation; 2021 Feb; 44(1):160-173. PubMed ID: 32856219
[TBL] [Abstract] [Full Text] [Related]
13. Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W.
Chae YK; Hong F; Vaklavas C; Cheng HH; Hammerman P; Mitchell EP; Zwiebel JA; Ivy SP; Gray RJ; Li S; McShane LM; Rubinstein LV; Patton D; Williams PM; Hamilton SR; Mansfield A; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
J Clin Oncol; 2020 Jul; 38(21):2407-2417. PubMed ID: 32463741
[TBL] [Abstract] [Full Text] [Related]
14. Lack of Targetable fgfr2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma.
Kongpetch S; Jusakul A; Lim JQ; Ng CCY; Chan JY; Rajasegaran V; Lim TH; Lim KH; Choo SP; Dima S; Popescu I; Duda DG; Kukongviriyapan V; Khuntikeo N; Pairojkul C; Rozen SG; Tan P; Teh BT
JCO Glob Oncol; 2020 Apr; 6():628-638. PubMed ID: 32315234
[TBL] [Abstract] [Full Text] [Related]
15. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract] [Full Text] [Related]
16. Bone Marrow Multipotent Mesenchymal Stromal Cells in Patients with Diffuse Large B-Cell lymphoma.
Fastova EA; Magomedova AU; Petinati NA; Sats NV; Kapranov NM; Davydova YO; Drize NI; Kravchenko SK; Savchenko VG
Bull Exp Biol Med; 2019 May; 167(1):150-153. PubMed ID: 31183651
[TBL] [Abstract] [Full Text] [Related]
17. Erdafitinib: First Global Approval.
Markham A
Drugs; 2019 Jun; 79(9):1017-1021. PubMed ID: 31161538
[TBL] [Abstract] [Full Text] [Related]
18. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract] [Full Text] [Related]
19. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma.
Chang Lee R; Sukumaran S; Koczwara B; Woodman R; Kichenadasse G; Roy A; Vatandoust S; Karapetis C
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1148. PubMed ID: 32721085
[TBL] [Abstract] [Full Text] [Related]
20. Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia.
Jerchel IS; Hoogkamer AQ; Ariës IM; Boer JM; Besselink NJM; Koudijs MJ; Pieters R; den Boer ML
Sci Rep; 2019 Feb; 9(1):1875. PubMed ID: 30755670
[TBL] [Abstract] [Full Text] [Related]
[Next]
